Frankfurt - Delayed Quote EUR
Aurinia Pharmaceuticals Inc. (IKAP.F)
7.06
+0.07
+(0.97%)
At close: April 25 at 9:39:01 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
550,645
548,062
470,860
543,367
Total Liabilities Net Minority Interest
173,167
170,108
65,425
64,276
Total Equity Gross Minority Interest
377,478
377,954
405,435
479,091
Total Capitalization
377,478
377,954
405,435
479,091
Common Stock Equity
377,478
377,954
405,435
479,091
Capital Lease Obligations
79,369
97,607
8,088
8,739
Net Tangible Assets
373,123
372,977
399,010
470,687
Working Capital
348,833
347,612
396,432
472,678
Invested Capital
377,478
377,954
405,435
479,091
Tangible Book Value
373,123
372,977
399,010
470,687
Total Debt
79,369
97,607
8,088
8,739
Share Issued
140,883
143,833
142,268
141,600
Ordinary Shares Number
140,883
143,833
142,268
141,600
12/31/2021 - 12/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade